SEEL
Seelos Therapeutics, Inc. Common Stock
SEEL
SEEL
Delisted
SEEL was delisted on the 15th of October, 2024.
68 hedge funds and large institutions have $27.1M invested in Seelos Therapeutics, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 11 increasing their positions, 13 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
15% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 13
Holders
68
Holding in Top 10
–
Calls
$749K
Puts
$129K
Top Buyers
| 1 | +$798K | |
| 2 | +$686K | |
| 3 | +$119K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$63.4K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$57K |
Top Sellers
| 1 | -$501K | |
| 2 | -$187K | |
| 3 | -$124K | |
| 4 |
MCM
MAI Capital Management
Independence,
Ohio
|
-$91.7K |
| 5 |
BAM
Belpointe Asset Management
Reno,
Nevada
|
-$34.6K |